产品型号:GSH2蛋白抗体 产品厂商:KALANG 产品文档: 简单介绍: Anti-GSH2抗体产品质量稳定,实验效果明显,货期快,价格优惠,欢迎垂询订购!我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-GSH...
Anti-Gsh1抗体产品质量稳定,实验效果明显,货期快,价格优惠,欢迎垂询订购!我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-Gsh1抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC...
Anti-GSH2 Product NameAnti-GSH2 CAS MF MW0 EINECS MOL FileMol File Chemical Properties storage temp.-20°C formbuffered aqueous solution biological sourcerabbit Usage And Synthesis Anti-GSH2 Supplier
The amphiphilic block polymer-doxorubicin(DOX) prodrug was employed to deliver a hydrophobic photosensitizer(PS), chlorin e6(Ce6), and the as-prepared nanoscale system [NPs(Ce6)] was investigated as a chemo-photodynamic anti-cancer agent. The glutathione(GSH)-cleavable disulfide bond was inserted...
产品名称:GSH1 谷氨酰半胱氨酸合成酶,Goat IgG anti-Mouse/Rat/Human,WB/ .0订购此产品 供应商:Santa 规格:200ug 目录价:￥:2980 库存状态: CAS编号: 应用范围: 种属来源: 相关信息: 保存条件: 说明书地址:点击查看详细 打印此页关闭此页 上一个:GSH1,Goat IgG anti-Mouse/Rat/Human,WB/[sc-15085/...
It was detected heur:trojan.androidos.boogr.gsh I hope you can help me, if not pls show me how to do factory reset , that is the last thing i want to do but if i have to then i gotta do this. And how do you save important stuff?
GSH-Pt adductsnon-toxicityPt drug inactivationPt6GS4Platinum (Pt) drugs are widely used in antiヽancer treatment although many reports advocated that tumor cells could inactivate Pt drugs via glutathione㏄t (GSH㏄t) adducts formation. To date, GSH chelated Pt molecules have not been assessed in...
In this work, novel size-appropriate and glutathione (GSH)-responsive nano-hydrogels were successfully prepared via the active ester method between chitosan (containing -NH2) and cross-linker (containing NHS). Especially, the cross-linker was elaborately designed to possess a disulfide linkage (SS)...
500 kgЦенаДоговорная Спецификации Ширина150–240 см. Вес120 г/м2 СтильПечатный ПриложениеДомашнийТекстиль, Одежда, Плат...
- 1995 - A1047 - www.sciencedirect.comdoi:10.1016/0016-5085(95)28491-5None